These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16871462)
61. Drug Design--SMi's Third Annual Conference. 23-24 February 2004, London UK. Austin S IDrugs; 2004 Apr; 7(4):331-3. PubMed ID: 15057638 [No Abstract] [Full Text] [Related]
62. Superbugs and Superdrugs--SMi's Sixth Annual Conference. A focus on antibacterials. 1-2 March 2004, London, UK. Lunec A IDrugs; 2004 Apr; 7(4):323-6. PubMed ID: 15057635 [No Abstract] [Full Text] [Related]
64. Voltage-gated sodium channels and hyperalgesia. Lai J; Porreca F; Hunter JC; Gold MS Annu Rev Pharmacol Toxicol; 2004; 44():371-97. PubMed ID: 14744251 [TBL] [Abstract][Full Text] [Related]
65. Targeting TRPV1 for pain relief: limits, losers and laurels. Szallasi A; Sheta M Expert Opin Investig Drugs; 2012 Sep; 21(9):1351-69. PubMed ID: 22780443 [TBL] [Abstract][Full Text] [Related]
66. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Scott DA; Wright CE; Angus JA Pain; 2004 May; 109(1-2):124-31. PubMed ID: 15082134 [TBL] [Abstract][Full Text] [Related]
67. The Seventh Annual Ion Channel Retreat Vancouver, Canada, June 29-July 1, 2009. Brugger S; Kennedy S; King N Assay Drug Dev Technol; 2010 Feb; 8(1):19-26. PubMed ID: 20158438 [TBL] [Abstract][Full Text] [Related]
68. Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014). Lee Y; Hong S; Cui M; Sharma PK; Lee J; Choi S Expert Opin Ther Pat; 2015 Mar; 25(3):291-318. PubMed ID: 25666693 [TBL] [Abstract][Full Text] [Related]
69. The discovery and development of analgesics: new mechanisms, new modalities. Burgess G; Williams D J Clin Invest; 2010 Nov; 120(11):3753-9. PubMed ID: 21041957 [TBL] [Abstract][Full Text] [Related]
70. Adaptive designs in clinical drug development - SMi's second annual conference. Tidwell K IDrugs; 2008 Apr; 11(4):263-6. PubMed ID: 18379959 [No Abstract] [Full Text] [Related]
71. Accelerating Patient Recruitment and Retention in Clinical Trials--SMi's fourth annual conference. Ogbighele E IDrugs; 2008 May; 11(5):334-6. PubMed ID: 18465673 [No Abstract] [Full Text] [Related]
72. Vaccines: from bench to bedside--SMi's third biannual conference. 22-23 May 2006, London, UK. Turner B IDrugs; 2006 Jul; 9(7):464-6. PubMed ID: 16821154 [No Abstract] [Full Text] [Related]
73. Advances and Progress in Drug Design--SMi's Seventh Annual Conference. Shumoogam J IDrugs; 2008 May; 11(5):337-9. PubMed ID: 18465674 [No Abstract] [Full Text] [Related]
74. The how and why of chronic pain states and the what of new analgesia therapies. Dray A; Rang H Trends Neurosci; 1998 Aug; 21(8):315-7. PubMed ID: 9720594 [No Abstract] [Full Text] [Related]
75. SMi's Global Protein Summit. 7-8 June 2006, London, UK. Greener M IDrugs; 2006 Aug; 9(8):551-3. PubMed ID: 16871463 [No Abstract] [Full Text] [Related]
77. [The 3rd International Congress "The World Institute of Pain" (an analytical review)]. Osipova NA; Abuzarova GR Anesteziol Reanimatol; 2005; (5):73-6. PubMed ID: 16318061 [No Abstract] [Full Text] [Related]
78. Society for Neuroscience--34th annual meeting. Pain. 23-27 October 2004, San Diego, CA, USA. Mackonochie M; Phillips T IDrugs; 2004 Dec; 7(12):1077-80. PubMed ID: 15599797 [No Abstract] [Full Text] [Related]
80. [Report and prospects of 15 years of research on pain]. Campan L; Lazorthes G Ann Anesthesiol Fr; 1977 Jul; 18(3):247-52. PubMed ID: 20001 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]